Neil Upton PhD
Neil is the author of several patents, over 200 publications and a Fellow of the British Pharmacological Society. His drug discovery know-how is renowned throughout the industry.
From taking a pivotal role at the helm of up to 40 preclinical and clinical translational scientists specializing in diverse CNS and GI indications to being strategic leader on several portfolios including Alzheimer’s disease, schizophrenia, pain, epilepsy and sleep disorders. Neil has also taken molecules directed to numerous targets through Discovery and into clinical trials. These include 5-HT6, H3 and OX1/2 receptors and GAP junction modulators.
When Neil can be dragged away from the lab he can be found enjoying a pint of home grown ale at his son’s Brewery.